Integrated Biomarker And Imaging Study - 2

NCT00268996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: SB-480848
DRUG: SB-480848 matching placebo

Sponsor

GlaxoSmithKline